Bio-Reference Labs (BRLI) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Join SI Premium – FREE
Bio-Reference Labs (NASDAQ: BRLI) reported Q4 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $227.6 thousand versus the consensus estimate of $228.81 thousand.
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- Carter's (CRI) Tops Q3 EPS by 15c; updates outlook
- Jefferies Reiterates Buy Rating on InterGlobe Aviation Ltd. (INDIGO:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
